| Autor: |
Garcia, Jacqueline S., Platzbecker, Uwe, Odenike, Olatoyosi, Fleming, Shaun, Fong, Chun Yew, Borate, Uma, Jacoby, Meagan A., Nowak, Daniel, Baer, Maria R., Peterlin, Pierre, Chyla, Brenda, Wang, Huipei, Ku, Grace, Hoffman, David, Potluri, Jalaja, Garcia-Manero, Guillermo |
| Zdroj: |
Blood; 20250101, Issue: Preprints |
| Abstrakt: |
•Venetoclax (14 days) + azacitidine regimen was well tolerated in patients with treatment-naive HR MDS, with no unexpected safety findings.•The regimen produced CR in 29.9% of patients, marrow CR in 50.5%, and 26-month median OS. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
